Fig. 1From: A prospective phase-II trial of biweekly docetaxel plus androgen deprivation therapy in patients with previously-untreated metastatic castration-naïve prostate cancerWaterfall plot of nadir PSA in chemotherapy-naïve prostate cancer patients (N = 42) treated with biweekly docetaxel plus androgen-deprivation therapyBack to article page